Air Methods (Nasdaq: AIRM ) is expected to report Q4 earnings on Feb. 28. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Air Methods's revenues will expand 5.8% and EPS will expand 15.8%.
The average estimate for revenue is $204.6 million. On the bottom line, the average EPS estimate is $0.44.
Last quarter, Air Methods booked revenue of $221.3 million. GAAP reported sales were 20% higher than the prior-year quarter's $185.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.71. GAAP EPS of $0.71 for Q3 were 48% higher than the prior-year quarter's $0.48 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 43.5%, 150 basis points better than the prior-year quarter. Operating margin was 24.3%, 440 basis points better than the prior-year quarter. Net margin was 12.6%, 260 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $839.8 million. The average EPS estimate is $2.28.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 268 members out of 286 rating the stock outperform, and 18 members rating it underperform. Among 77 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 74 give Air Methods a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Air Methods is outperform, with an average price target of $40.93.
Is Air Methods the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.